Income StatementBalance SheetCash FlowSegments
International Flavors & Fragrances logo

International Flavors & Fragrances Business Segments

Business, geographic, and product segment breakdowns

International Flavors & Fragrances generates $10.8B in annual revenue across 4 key segments: Food Ingredients ($3.3B), Health & Biosciences ($2.3B), Scent ($2.5B), and Taste ($2.5B). The company-wide operating margin is -1.91%. Based on the Q1 2026 filing.

Food Ingredients (TTM)$3.3BHealth & Biosciences (TTM)$2.3BScent (TTM)$2.5BTaste (TTM)$2.5B
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$19.9B
P/E Ratio24.26
ROE6.02%

Geographic

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net sales attributed to all foreign countries—$2.0B$2.0B$2.0B—$2.0B
Europe, Africa and Middle East$927.0M$952.0M$953.0M$933.0M$889.0M$949.0M
North America$812.0M$868.0M$803.0M$779.0M$745.0M$788.0M
Greater Asia$674.0M$670.0M$647.0M$617.0M$612.0M$656.0M
Latin America$358.0M$353.0M$361.0M$365.0M$343.0M$348.0M

Concentration risk threshold

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Foreign Countries2.5%2.5%2.5%2.5%2.5%—

Property, plant and equipment

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
United States$1.6B———$1.6B—

Maximum percentage of total consolidated net sales attributed to any non-U.S. country

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net sales attributed to all foreign countries—10.0%10.0%10.0%—10.0%

Business Segments

Adjusted Operating EBITDA

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences—$138.0M$151.0M$150.0M—$153.0M
Taste$87.0M$131.0M$125.0M$128.0M$94.0M$153.0M
Scent$106.0M$144.0M$130.0M$135.0M$106.0M$148.0M
Food Ingredients$100.0M$111.0M$124.0M$106.0M$82.0M$114.0M

Restructuring, expected cost

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients And Taste Segments————$130.0M—

Capital Expenditures

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$21.0M$40.0M$22.0M$37.0M$46.0M$55.0M
Food Ingredients$62.0M$60.0M$40.0M$59.0M$64.0M$50.0M
Scent$27.0M$24.0M$8.0M$21.0M$36.0M$36.0M
Taste$28.0M$27.0M$15.0M$15.0M$42.0M$24.0M
Pharma Solutions$22.0M$28.0M$10.0M$0.0$0.0$0.0

Cost of Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$630.0M$609.0M$642.0M$642.0M$638.0M$646.0M
Scent$330.0M$344.0M$336.0M$374.0M$370.0M$375.0M
Taste$360.0M$377.0M$377.0M$379.0M$367.0M$375.0M
Health & Biosciences—$298.0M$311.0M$315.0M—$327.0M

Depreciation Expense, Add-Back

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients-$32.0M$28.0M$34.0M$35.0M-$227.0M$34.0M
Health & Biosciences-$29.0M-$29.0M-$31.0M-$32.0M-$32.0M-$32.0M
Scent-$17.0M$15.0M$17.0M$17.0M-$116.0M$18.0M
Taste-$18.0M-$15.0M-$16.0M-$16.0M-$18.0M-$16.0M

Goodwill

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$4.3B$4.3B$4.5B$4.5B$4.5B$4.4B
Taste$0.0$2.2B$2.3B$2.3B$2.3B$2.3B
Scent$1.5B$1.5B$1.5B$1.5B$1.5B$1.5B
Food Ingredients$0.0$0.0$0.0$0.0$0.0$0.0

Goodwill, accumulated impairment loss

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients————$1.2B—
Health & Biosciences$2.3B———$2.3B—

Goodwill, Written off Related to Sale of Business Unit

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$0.0$0.0$0.0$0.0$0.0—
Health & Biosciences$0.0$0.0$0.0$0.0$0.0—
Nourish$2.5M$0.0$0.0$0.0$0.0—
Pharma Solutions$0.0$0.0$0.0$0.0$0.0—
Scent$0.0$0.0$0.0$0.0$0.0—
Taste$0.0$2.0M$2.0M$2.0M$2.0M—

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$819.0M$796.0M$850.0M$830.0M$802.0M$839.0M
Taste$576.0M$627.0M$631.0M$635.0M$588.0M$656.0M
Scent$578.0M$614.0M$603.0M$652.0M$610.0M$651.0M
Health & Biosciences$550.0M$540.0M$577.0M$577.0M$589.0M$595.0M

Research and development expenses

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$50.0M$52.0M$55.0M$57.0M$55.0M$55.0M
Scent$58.0M$55.0M$62.0M$63.0M$61.0M$54.0M
Taste$43.0M$40.0M$47.0M$41.0M$44.0M$43.0M
Food Ingredients$13.0M$12.0M$14.0M$13.0M$15.0M$14.0M

Restructuring Charges

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$13.0M$3.0M$7.0M$2.0M—$2.0M
Health & Biosciences—$3.0M$5.0M$4.0M—$2.0M
Taste$10.0M$2.0M$6.0M$9.0M$3.0M$2.0M
Scent$0.0$9.0M$3.0M$1.0M$8.0M$0.0

Selling and administrative expenses

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Taste$104.0M$94.0M$98.0M$103.0M$101.0M$101.0M
Food Ingredients$108.0M$92.0M$104.0M$104.0M$100.0M$99.0M
Health & Biosciences$95.0M$81.0M$91.0M$87.0M$89.0M$92.0M
Scent$101.0M$86.0M$92.0M$97.0M$91.0M$92.0M

Additional charges, net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$0.0$3.0M$5.0M$4.0M$7.0M$2.0M

Cost of Product and Service Sold

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$298.0M$298.0M$311.0M$315.0M$322.0M$327.0M

Foreign exchange

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences-$116.0M$60.0M$126.0M$0.0$5.0M-$22.0M
Taste—$39.0M$94.0M$0.0$9.0M-$20.0M
Scent-$29.0M$14.0M$32.0M——-$7.0M

Segment Adjusted Operating EBITDA

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$136.0M$138.0M$151.0M$150.0M$155.0M$153.0M